Among the reasons for the test’s rapid acceptance is that it’s non-invasive and can be done by patients at home. It begins with a shower, which helps break up mucus in the lungs. Then ...
bioAffinity VP served on expert panel that published new guidance SAN ANTONIO, October 16, 2024--(BUSINESS WIRE)--bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics ...
UK-based Cizzle Biotechnology signed the licensing agreement with its US-based partner, Cizzle Bio, for the commercialization of early cancer detection tests.
“Our CyPath® Lung noninvasive test for the early detection of lung cancer is a novel test that uses sputum, a unique sample type that is not typically used in clinical flow cytometry assays ...
Cizzle Biotechnology Holdings plc (Cizzle), the UK based diagnostics developer, is pleased to announce that it has signed an exclusive licensing agreement with Cizzle Bio granting exclusive rights to ...